FIELD: satisfaction of vital human requirements.
SUBSTANCE: present invention relates to a method for assessing the clinical effectiveness of lipidemia by laboratory examination of blood lipids before and after treating lipidemia with subsequent determination of the atherogenic coefficient, wherein before and after treatment of lipidemia, the ratio (TCS+TAG)/CS of HDL is determined, and with simultaneous reduction of this ratio to 4.0 standard units and the total cholesterol level by 20 % and more from the initial value, the lipidemia treatment is evaluated as highly effective, and with simultaneous reduction of total cholesterol by 19 % and lower and reduction of the above atherogenic coefficient to 4.1 and more, the treatment of lipidemia is considered to be low-effective.
EFFECT: high accuracy of assessing the clinical effectiveness of lipidemia using a simple method which does not require high material costs.
1 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF CLINICAL COURSE OF LIPIDEMIA | 2019 |
|
RU2714689C1 |
| METHOD FOR DIAGNOSING LIPIDEMIA | 2019 |
|
RU2694531C1 |
| DIAGNOSTIC TECHNIQUE FOR EARLY AND LATE STAGES OF LIPIDEMIA | 2019 |
|
RU2694538C1 |
| METHOD FOR PREDICTION OF POSSIBLE THROMBOGENIC COMPLICATIONS IN ATHEROGENIC GENESIS LIPIDEMIA AND CLINICAL DIAGNOSIS OF STRESS ANGINA OF DIFFERENT FUNCTIONAL CLASSES | 2019 |
|
RU2721687C1 |
| METHOD FOR ASSESSING A POSSIBLE HIGH, MODERATE AND LOW RISK OF THROMBOGENIC COMPLICATIONS OF ISCHEMIC HEART DISEASE COURSE | 2019 |
|
RU2721877C1 |
| METHOD FOR ASSESSING PROGRESSION OF ATHEROGENICITY IN ISCHEMIC HEART DISEASE | 2013 |
|
RU2521322C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF LIPIDEMIA | 2013 |
|
RU2517054C1 |
| METHOD FOR EVALUATING CLINICAL EFFECTIVENESS IN LIPIDEMIA | 2011 |
|
RU2462718C1 |
| AGENT POSSESSING HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTIVITY | 2015 |
|
RU2598347C1 |
| DIAGNOSTIC TECHNIQUE FOR LIPIDEMIA | 2011 |
|
RU2476888C1 |
